Cargando…
Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma–Carcinoma Pathway Progression
PURPOSE: Colorectal cancer (CRC) can develop via a hypermutagenic pathway characterized by frequent somatic DNA base-pair mutations. Alternatively, the immunogenicity of tumor cells themselves may influence the anticancer activity of the immune effector cells. Impaired DNA repair mechanisms drive mu...
Autores principales: | Zhang, Yu, Zhang, Xin, Jin, Zhuoyi, Chen, Huiyan, Zhang, Chenjing, Wang, wangyue, Jing, Jiyong, Pan, Wensheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559027/ https://www.ncbi.nlm.nih.gov/pubmed/34737598 http://dx.doi.org/10.2147/JIR.S331010 |
Ejemplares similares
-
XRCC2 (X-ray repair cross complementing 2)
por: Andreassen, Paul R, et al.
Publicado: (2019) -
X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone –induced apoptosis in pancreatic cancer cells
por: Zheng, Yansong, et al.
Publicado: (2021) -
Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study
por: Skjelbred, Camilla Furu, et al.
Publicado: (2006) -
X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia: A Meta-Analysis
por: Wang, Libing, et al.
Publicado: (2012) -
A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk
por: Patel, Alpa V, et al.
Publicado: (2005)